THE USE OF SGC STIMULATORS, SGC ACTIVATORS, ALONE AND COMBINATIONS WITH PDE5 INHIBITORS FOR THE TREATMENT OF DIGITAL ULCERS (DU) CONCOMITANT TO SYSTEMIC SCLEROSIS (SSC)

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

FOLLMANN, Markus,HAHN, Michael,HIRTH-DIETRICH, Claudia,SANDNER, Peter,STASCH, Johannes-Peter,VAKALOPOULOS, Alexandros

申请号：

TN2017000465

公开号：

TN2017000465A1

申请日:

2016.05.02

申请国别(地区):

TN

年份:

2019

代理人:

摘要：

Use of sGC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and healing of Digital Ulcers which are concomitant to fibrotic diseases, such as systemic sclerosis and scleroderma.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/